FDA Warns Indian Drugmaker and ORI Finds Research Misconduct

September 4, 2019

The Food and Drug Administration (FDA) recently sent a warning letter to CTX Lifesciences Private Ltd. In Surat, India, and the Office of Research Integrity (ORI) issued a notice on research misconduct.

Related Stories